Top

Published in:

01-06-2014 | Review

Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature

Authors: Krys Milburn, Vinayak Bapat, Martyn Thomas

Published in: Clinical Research in Cardiology | Issue 6/2014

Abstract

Transcatheter aortic valve implantation has established itself as an alternative treatment for patients with valvular disease. In the current context of increasing bioprosthetic valve implants and an ageing population with growing comorbidities, a less invasive approach to the treatment of bioprosthetic dysfunction would be an appealing alternative to the standard of care. Transcatheter valve-in-valve implantation could be an alternative for patients who are deemed to be a high surgical risk. The valve-in-valve procedure is a minimally invasive percutaneous procedure where a valve can be implanted directly within a failing bioprosthetic valve. This technique can be applied to dysfunctional aortic bioprosthetic valves and can also be used in the pulmonary and atrioventricular valve bioprosthesis. We review the current literature to assess whether this technique may be the new standard for degenerated bioposthesis.

Kodali SK, Williams MR, Smith CR et al (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366:1686–1695PubMedCrossRef

Gummert JF, Funkat A, Beckmann A et al (2008) Cardiac surgery in Germany during 2007: a report on behalf of the german society for thoracic and cardiovascular surgery. Thorac Cardiovasc Surg 56:328–336PubMedCrossRef

Brown JM, O’Brien SM, Wu C et al (2009) Isolated aortic valve replacements in North America comprising 108,687 patients in 10 years: changes in risk, valve types, and outcomes in the society of thoracic surgeons national database. J Thorac Cardiovasc Surg 137:82–90PubMedCrossRef

Jamieson WRE, Miyagishmas RT, Burr LH et al (2000) Carpentier-Edwards porcine bioprosthesis: clinical performance assessed by actual analysis. J Heart Valve Dis 9:530–535PubMed

David TE, Ivanov J (2003) Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves? J Thorac Cardiovasc Surg 126:939–941PubMedCrossRef

Nollert G, Miksch J, Kreuzer E et al (2003) Risk factors for atherosclerosis and degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg 126:965–968PubMedCrossRef

Piehler JM, Blackstone EH, Bailey KR et al (1995) Reoperation on prosthetic heart valves. Patient-specific estimates of in-hospital events. J Thorac Cardiovasc Surg 109:30–48PubMedCrossRef

Christiansen S, Schmid M, Autschbach R (2009) Perioperative risk of redo aortic valve replacement. Ann Thorac Cardiovasc Surg 15:105–110PubMed

Jones JM, O’Kane H, Gladstone DJ et al (2001) Repeat heart surgery: risk factors for operative mortality. J Thorac Cardiovasc Surg 122:913–918PubMedCrossRef

10.

Potter DD, Sundt TM 3rd, Zehr KJ et al (2005) Operative risk of reoperative aortic valve replacement. J Thorac Cardiovasc Surg 129:94–103PubMedCrossRef

11.

Jamieson WR, Burr LH, Miyagishima RT et al (2003) Re- operation for bioprosthetic aortic structural failure—risk assessment. Eur J Cardiothorac Surg 24:873–878PubMedCrossRef

12.

Leontyev S, Borger M, Davierwala et al (2011) Redo aortic valve surgery: early and late outcomes. Ann Thorac Surg 91:1120–1126PubMedCrossRef

13.

Crabtree TD, Bailey MS, Moon MR et al (2008) Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischaemic mitral regurgitation. Ann Thorac Surg 85:1537–1542PubMedCrossRef

14.

Akins CW, Buckley MJ, Daggett WM et al (1998) Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg 65:1545–1551 discussion 1551–2PubMedCrossRef

15.

Balsam LB, Grossi EA, Greenhouse DG et al (2010) Reoperative valve surgery in the elderly: predictors of risk and long-term survival. Ann Thorac Surg 90:1195–1200 discussion 1201PubMedCrossRef

16.

Maganti M, Rao V, Armstrong S, Feindel CM, Scully HE, David TE (2009) Redo valvular surgery in elderly patients. Ann Thorac Surg 87:521–525PubMedCrossRef

17.

Tahta SA, Oury JH, Maxwell JM et al (2002) Outcome after mitral valve repair for functional ischaemic mitral regurgitation. J Heart Valve Dis 11:11–18PubMed

18.

Rizzoli G, Bottio T, De Perini L et al (1998) Multivariate analysis of survival after malfunctioning biological and mechanical prosthesis replacement. Ann Thorac Surg 66(6 suppl):S88–S94PubMedCrossRef

19.

Bove EL, Byrum CJ, Thomas FD et al (1983) The influence of pulmonary insufficiency on ventricular function following repair of tetralogy of Fallot. Evaluation using radionuclide ventriculography. J Thorac Cardiovasc Surg 85:691–696PubMed

20.

Dietl CA, Cazzangia ME, Dubner SJ et al (1994) Life-threatening arrhythmias and RV dysfunction after surgical repair of tetralogy of Fallot. Comparison between transventricular and transapical approaches. Circulation 90:7–12

21.

Lee C, Park CS, Lee CH, Kwak JG et al (2011) Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 142:351–358PubMedCrossRef

22.

Filsoufi F, Anyanwu AC, Salzberg SP et al (2005) Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg 80:845–850PubMedCrossRef

23.

Garatti A, Nano G, Bruschi G, Canziani A, Colombo T, Frigiola A et al (2012) Twenty-five year outcomes of tricuspid valve replacement comparing mechanical and biologic prostheses. Ann Thorac Surg 93:1146–1153PubMedCrossRef

24.

Hwang HY, Kim KH, Kim KB, Ahn H (2012) Mechanical tricuspid valve replacement is not superior in patients younger than 65 years who need long-term anticoagulation. Ann Thorac Surg 93:1154–1160PubMedCrossRef

25.

Van Nooten GJ, Caes F, Taeymans Y, Van Belleghem Y, Francois K, De Bacquer D et al (1995) Tricuspid valve replacement: postoperative and long-term results. J Thorac Cardiovasc Surg 110:672–679PubMedCrossRef

26.

Rizzoli G, Vendramin I, Nesseris G, Bottio T, Guglielmi C, Schiavon L (2004) Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results. Ann Thorac Surg 77:1607–1614PubMedCrossRef

27.

Jeganathan R, Armstrong S, Al-Alao B et al (2013) The risk and outcomes of reoperative tricuspid valve surgery. Ann Thorac Surg 93(1):119–124CrossRef

28.

Walther T, Falk V, Dewey T et al (2007) Valve-in-valve concept for transcatheter minimally invasive repeat xenograft implantation. J Am Coll Cardiol 50:56–60PubMedCrossRef

29.

Wenaweser P, Buellesfeld L, Gerckens U et al (2007) Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the CoreValve revalving system. Catheter Cardiovasc Interv 70:760–764PubMedCrossRef

30.

Seiffert M, Franzen O, Conradi L et al (2010) Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprosthesis in aortic and mitral position. Cath Cardiovasc Intv 76:608–615CrossRef

31.

Webb J, Wood D, Ye J et al (2010) Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 121:1848–1857PubMedCrossRef

32.

Piazza N, Bleiziffer S, Brockmann G et al (2011) Transcatheter aortic valve implantation for failing surgical aortic bioprosthesis: from concept to clinical application and evaluation (part 2). J Am Coll Cardiol Intv 4:733–742CrossRef

33.

Ussia G, Barbanti M, Ramondo A et al (2011) The valve-in-valve technique for treatment of aortic bioprosthesis malposition: an analysis of incidence and 1-year clinical outcomes from the Italian CoreValve registry. J Am Coll Cardiol 57:1062–1068PubMedCrossRef

34.

Bapat V, Attia R, Redwood S et al (2012) Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results. J Thorac Cardiovasc Surg 144:1372–1380PubMedCrossRef

35.

Dvir D, Webb J, Brecker S et al (2012) Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation 126:2335–2344PubMedCrossRef

36.

Cerillo AG, Chiaramonti F, Murzi M et al (2011) Transcatheter valve in valve implantation for failed mitral and tricuspid bioprosthesis. Catheter Cardiovasc Interv 78:987–995PubMedCrossRef

37.

Cheung A, Webb JG, Wong DR et al (2009) Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg 87:e18–e20PubMedCrossRef

38.

Cheung AW, Gurvitch R, Ye J et al (2011) Transcatheter transapical mitral valve-in-valve implantations for a failed bioprosthesis: a case series. J Thorac Cardiovasc Surg 141:711–715PubMedCrossRef

39.

de Weger A, Tavilla G, Ng AC et al (2010) Successful transapical transcatheter valve implantation within a dysfunctional mitral bioprosthesis. J Am Coll Cardiol Img 3:222–223CrossRef

40.

Gaia DF, Palma JH, de Souza JA et al (2012) Transapical mitral valve-in-valve implant: an alternative for high risk and multiple reoperative rheumatic patients. Int J Cardiol 154:e6–e7PubMedCrossRef

41.

Núñez-Gil IJ, Gonçalves A, Rodrıguez E et al (2011) Transapical mitral valve-in-valve implantation: a novel approach guided by three- dimensional transoesophageal echocardiography. Eur J Echocardiogr 12:335–337PubMedCrossRef

42.

van Garsse LA, Gelsomino S, van Ommen V, Luca F, Maessen J (2011) Emergency transthoracic transapical mitral valve-in-valve implantation. J Interv Cardiol 24:474–476PubMedCrossRef

43.

Bruschi G, Barosi A, Colombo P et al (2012) Direct transatrial transcatheter SAPIEN valve implantation through right minithoracotomy in a degenerated mitral bioprosthetic valve. Ann Thorac Surg 93:1708–1710PubMedCrossRef

44.

Montorfano M, Latib A, Chieffo A et al (2011) Successful percutaneous anterograde transcatheter valve-in-valve implantation in the mitral position. JACC Cardiovasc Interv 4:1246–1247PubMedCrossRef

45.

Cullen M, Cabalka A, Alli O et al (2013) Transvenous, antegrade melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. J Am Coll Cardiol Intv 6(6):598–605CrossRef

46.

Kempfert J, Blumenstein J, Chu M et al (2009) Minimally invasive off-pump valve-in-a-ring implantation: the atrial transcatheter approach for re-operative mitral valve replacement after failed repair. Eur J Cardiothorac Surg 35:965–969PubMedCrossRef

47.

Cheung A, Webb J, Barbanti M et al (2013) 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol 61:1759–1766PubMedCrossRef

48.

Casselman F, Martens S, De Bruyne B et al (2011) Reducing operative mortality in valvular reoperations: the “valve in ring” procedure. J Thorac Cardiovasc Surg 141:1317–1318PubMedCrossRef

49.

de Weger A, Ewe SH, Delgado V, Bax JJ (2011) First-in-man implantation of a trans-catheter aortic valve in a mitral annuloplasty ring: novel treatment modality for failed mitral valve repair. Eur J Cardiothorac Surg 39:1054–1056PubMedCrossRef

50.

Bonhoeffer P, Boudjemline Y, Saliba Z et al (2000) TRanscatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 102:813–816PubMedCrossRef

51.

Bonhoeffer P, Boudjemline Y, Saliba Z et al (2000) Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 356:1403–1405PubMedCrossRef

52.

Coats L, Khambadkone S, Derrick G et al (2007) Physiological consequences of percutaneous pulmonary valve implantation: the different behaviour of volume- and pressure-overloaded ventricles. Eur Heart J 28:1886–1893PubMedCrossRef

53.

Lurz P, Nordmeyer J, Muthurangu V, Khambadkone S, Derrick G, Yates R, Sury M, Bonhoeffer P, Taylor AM (2009) Comparison of bare metal stenting and percutaneous pulmonary valve implantation for treatment of right ventricular outflow tract obstruction: use of an X-ray/magnetic resonance hybrid laboratory for acute physiological assessment. Circulation 119:2995–3001PubMedCrossRef

54.

Doff B, McElhinney W, Hellebrand E et al (2010) Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicentre US Melody valve trial. Circulation 122:507–516CrossRef

55.

Nordmeyer J, Coats L, Lurz P et al (2008) Percutaneous pulmonary valve-in-valve implantation: a successful treatment concept for early device failure. Eur Heart J 29:810–815PubMedCrossRef

56.

Garay F, Webb J, Hijazi ZM (2006) Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv 67:659–662PubMedCrossRef

57.

Boone RH, Webb JG, Horlick E et al (2010) Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc Interv 75:286–294PubMedCrossRef

58.

Kenny D, Hijazi Z, Kar S et al (2011) Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicentre clinical trial. J Am Coll Cardiol 58:2248–2256PubMedCrossRef

59.

Ewert P, Horlick E, Berger F (2011) First implantation of the CE-marked transcatheter SAPIEN pulmonic valve in Europe. Clin Res Cardiol 58:2248–2256

60.

Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB (2009) Implantation of the Melody transcatheter pulmonary valve in patients with dysfunctional right ventricular outflow tract conduits: early results from the U.S. clinical trial. J Am Coll Cardiol 54:1722–1729PubMedCrossRef

61.

Hon JK, Cheung A, Ye J et al (2010) Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis. Ann Thorac Surg 90:1696–1697PubMedCrossRef

62.

Van Garsse LA, Ter Bekke RM, van Ommen VG (2011) Percutaneous trans-catheter valve-in-valve implantation in stenosed tricuspid valve bio- prosthesis. Circulation 8:123

63.

Cerillo AG, Berti S, Glauber M (2011) Transjugular tricuspid valve-in-valve implantation: a safe and effective approach. Ann Thorac Surg 92:777–778PubMedCrossRef

64.

Calvert PA, Himbert D, Brochet E et al (2012) Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks. EuroIntervention 7:1336–1339PubMedCrossRef

65.

Roberts P, Spina R, Vallely M et al (2011) Percutaneous tricuspid valve replacement for a stenosed bioprosthesis. Circ Cardiovasc Interv 3:e14–e15CrossRef

66.

Riede FT, Dahnert I (2012) Implantation of a Melody valve in tricuspid position. Catheter Cardiovas Interv 80:474–476CrossRef

67.

Roberts PA, Boudjemline Y, Cheatham JP et al (2011) Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol 58:117–122PubMedCrossRef

68.

Bonow RO, Carabello BA, Kanu C et al (2006) ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American heart association task force on practice guidelines: developed in collaboration with the society of cardiovascular anesthesiologists: endorsed by the society of cardiovascular angiography and interventions and the society of thoracic surgeons. Circulation 114:e84–e231PubMedCrossRef

69.

Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European society of cardiology. Eur Heart J 28:230–268PubMed

70.

Cheung A, Al-Lawati A (2013) Transcatheter mitral valve-in-valve implantation: current experience and review f the literature. Curr Opin Cardiol 28:181–186PubMedCrossRef

71.

Weich H, Janson J, van Wyk J et al (2011) Transjugular tricuspid valve-in-valve replacement. Circulation 124:157–160CrossRef

72.

Grünenfelder J, Plass A, Alkadhi H et al (2008) Evaluation of biological aortic valve prostheses by dual source computer tomography and anatomic measurements for potential transapical valve-in-valve procedure. Interact CardioVasc Thorac Surg 7:195–200PubMedCrossRef

73.

Rahimtoola SH (1978) The problem of valve prosthesis–patient mismatch. Circulation 58:20–24PubMedCrossRef

74.

Pibarot P, Dumesnil JG (2006) Prosthesis–patient mismatch: definition, clinical impact, and prevention. Heart 92:1022–1029PubMedCentralPubMedCrossRef

75.

Blais C, Dumesnil J, Baillot R et al (2003) Impact of valve prosthesis–patient mismatch on short term mortality after aortic valve replacement. Circulation 108:983–988PubMedCrossRef

76.

Seiffert M, Conradi L, Baldus S et al (2012) Impact of patient–prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprosthesis. J Thorac Cardiovasc Surg 143:617–624PubMedCrossRef

77.

Azadani A, Jaussaud N, Matthews P et al (2010) Transcatheter aortic valves inadequately relieve stenosis in small degenerative bioprosthesis. Interact Cardiovasc Thorac Surg 11:70–77PubMedCrossRef

78.

Eggebrecht H, Schafer U, Treede H et al (2011) Vavle-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. J Am Coll Cardiovasc Intv 4:1218–1227CrossRef

79.

Myotte D, Lange R, Marucci G et al (2013) Transcatheter heart valve implantation for failing surgical bioprostheses: technical considerations and evidence for valve-in-valve procedures. Heart 00:1–8

80.

Bapat V, Mydin I, Chadalavada S et al (2013) A guide to fluoroscopic evaluation and design of bioprosthetic valves: a reference for valve-in-valve procedure. Catheter Cardiovasc Interv 81(5):853–861PubMedCrossRef

81.

Toggweiler S, Wood D, Rodes-Cabau J et al (2012) Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. J Am Coll Cardiol Intv 5:571–577CrossRef

82.

Makkar R, Jilaihawi H, Chakravarty T et al (2013) Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolisation: a study of multiple valve implants in the US Partner trial. J Am Coll Cardiol 62(5):418–430PubMedCrossRef

83.

Kempfert J, Rastan A, Schuler G et al (2011) A second prosthesis as a procedural rescue option in trans-apical aortic valve implantation. Eur J Cardiothorac Surg 40:56–60PubMedCrossRef

84.

Thomas M, Schymik G, Walther T et al (2010) Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (Source) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122:62–69PubMedCrossRef

85.

Piazza N, Grube E, Gerckens U et al (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18Fr) CoreValve revalving system: results from the multicentre expanded evaluation registry 1-year following CE mark approval. Eurointervention 4:242–249PubMedCrossRef

86.

Leon MB, Smith CR, Mack M et al (2010) Partner trial investigators. Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607PubMedCrossRef

87.

Smith CR, Leon MB, Mack MJ et al (2011) Partner trial investigators. Transcatheter vs. surgical aortic valve replacement in high-risk patients with severe aortic stenosis. N Engl J Med 361:2187–2198CrossRef

88.

Van Linden A, Blumenstein J, Walther W et al (2013) Rescue valve-in-valve implantations in second generation transapical transcatheter aortic valve prostheses. Clin Res Cardiol 102:241–243PubMedCrossRef

89.

Ribeiro H, Nombela-Franco L, Urena M et al (2013) Coronary obstruction following transcatheter aortic valve implantation. A systematic review. J Am Coll Cardiol Intv 6:453–461CrossRef

90.

Chakravarty T, Jilaihawi H, Nakamura M et al (2013) Pre-emptive positioning of a coronary stent in the left anterior descending artery for left main protection: a prerequisite for transcatheter aortic valve-in-valve implantation for failing stentless bioprostheses? Catheter Cardiovasc Interv 82:E630–E636. doi:10.1002/ccd.25037 PubMed

91.

Jilaihawi H, Chakravarty T, Weiss RE et al (2012) Meta-analysis of the complications in aortic valve replacement: comparison of medtronic corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Cath Cardiovasc Int 80(1):128–138CrossRef

92.

Genereux P, Head SJ, Van Mieghenm NM et al (2012) Clinical outcomes after transcatheter aortic valve replacement using valve acaedemic research consortium definitions: a weighted Meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 59(25):2317–2326PubMedCrossRef

93.

Raffa H, Al-Ibrahim K, Sorefan A et al (1991) Superimposition of a mechanical valve on an impacted aortic bioprosthesis. Te Heart Inst J 18:199–201

Title: Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature
Authors: Krys Milburn
Vinayak Bapat
Martyn Thomas
Publication date: 01-06-2014
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 6/2014
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-013-0653-3

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2014

Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections

Fast pathway ablation for atrioventricular nodal reentrant tachycardia with a marked PR interval prolongation during sinus rhythm following transcatheter aortic valve implantation

Classification of diastolic function with phase-contrast cardiac magnetic resonance imaging: validation with echocardiography and age-related reference values

High-grade angiosarcoma of the right atrium successfully targeted with total resection and reconstruction followed by adjuvant chemotherapy

Anemia is associated with an increased central venous pressure and mortality in a broad spectrum of cardiovascular patients

Successful ablation of a bioresorbable polymeric vascular scaffold by rotational atherectomy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page